Clinical Trial Update: Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control

View source ↗

Summary

This trial update analyzes lymphocyte cell surface adhesion marker expression in Natalizumab-treated MS patients using an active-control comparison. The report …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: John F. Foley, MD | Conditions: Multiple Sclerosis | Status: COMPLETED